Lexston Life Sciences Corp
CNSX:LEXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lexston Life Sciences Corp
CNSX:LEXT
|
CA |
|
Rossiyskiy Aktsionernyi Kommercheskiy Dorozhnyi Bank PAO
MOEX:RDRB
|
RU |
Bankruptcy Probability
Lexston Life Sciences Corp's probability of bankruptcy is 2.1%, pointing to a small but noticeable default risk. The solvency score is 63/100 — a warning sign of potential financial weakness.
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Lexston Life Sciences Corp Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
L
|
Lexston Life Sciences Corp
CNSX:LEXT
|
1.3m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| BM |
|
Roivant Sciences Ltd
NASDAQ:ROIV
|
24.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
I
|
Intra-Cellular Therapies Inc
F:23I
|
13B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
B
|
Blueprint Medicines Corp
F:2L9
|
7.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Cidara Therapeutics Inc
F:20D0
|
5.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
A
|
Amicus Therapeutics Inc
F:AM6
|
3.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DE |
|
MorphoSys AG
NASDAQ:MOR
|
2.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| SE |
|
BioArctic AB
STO:BIOA B
|
25.5B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
BGI Genomics Co Ltd
SZSE:300676
|
17B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
Sino Biological Inc
SZSE:301047
|
15.1B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| SE |
|
AddLife AB
STO:ALIF B
|
22.1B SEK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Lexston Life Sciences Corp's probability of bankruptcy is 2.1%, pointing to a small but noticeable default risk.
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Lexston Life Sciences Corp has total debt of 8k CAD. This includes both short-term (8k CAD) and long-term (0 CAD) debt.
You can find a full breakdown on its Balance Sheet.